Complete remission after single agent blinatumomab in a patient with pre-B acute lymphoid leukemia relapsed and refractory to three prior regimens: hyperCVAD, high dose cytarabine mitoxantrone and CLAG
Crossref DOI link: https://doi.org/10.1186/s40164-016-0051-4
Published Online: 2016-07-26
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Linder, Katherine
Gandhiraj, Deepthi
Hanmantgad, Madhura
Seiter, Karen
Liu, Delong